Literature DB >> 30456645

[Incidental finding of mucinous neoplasia of the appendix : Treatment strategies].

F Köhler1, M Rosenfeldt2, N Matthes1, C Kastner1, C-T Germer1,3, A Wiegering4,5,6.   

Abstract

Tumors of the appendix are not a uniform group but differ significantly in terms of their origin/histology and metastatic behavior. Furthermore, tumors of the appendix are often diagnosed as incidental findings after appendectomy for acute appendicitis. A subgroup of these neoplasms are low-grade appendiceal mucinous neoplasms (LAMN). These are mucus-forming tumors of the appendiceal lumen, which can lead to rupture of the appendix and seeding into the abdominal cavity. Therefore LAMN are considered precursors of pseudomyxoma peritonei (PMP). It is essential to clearly differentiate the subgroups of LAMN as well as the resection status. According to this it is determined whether (radical) appendectomy is a sufficient therapy or further treatment, such as ileocecal resection with hyperthermic intraperitoneal chemotherapy (HIPEC) or cytoreductive surgery (CRS) is necessary. There is no standardized concept regarding the follow-up after resection of LAMN. Generally, it is recommended to perform a computed tomography (CT) scan of the abdomen and determination of tumor markers 6 months postoperatively and then once a year. A recommendation regarding the duration of follow-up is difficult as there are case reports in which PMP has occurred more than 15 years after removal of LAMN.

Entities:  

Keywords:  Classification; Hyperthermic intraperitoneal chemotherapy; Low-grade mucinous neoplasia; Pseudomyxoma peritonei; Surgery

Mesh:

Year:  2019        PMID: 30456645     DOI: 10.1007/s00104-018-0768-1

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  15 in total

1.  Pseudomyxoma peritonei.

Authors:  Katharine E Bevan; Faheez Mohamed; Brendan J Moran
Journal:  World J Gastrointest Oncol       Date:  2010-01-15

2.  Risk-reducing laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for low-grade appendiceal mucinous neoplasm: early outcomes and technique.

Authors:  Rebecca Fish; Chelliah Selvasekar; Peter Crichton; Malcolm Wilson; Paul Fulford; Andrew Renehan; Sarah O'Dwyer
Journal:  Surg Endosc       Date:  2013-09-06       Impact factor: 4.584

3.  Recommendations in the management of epithelial appendiceal neoplasms and peritoneal dissemination from mucinous tumours (pseudomyxoma peritonei).

Authors:  P Barrios; F Losa; S Gonzalez-Moreno; A Rojo; A Gómez-Portilla; P Bretcha-Boix; I Ramos; J Torres-Melero; R Salazar; M Benavides; T Massuti; E Aranda
Journal:  Clin Transl Oncol       Date:  2015-10-21       Impact factor: 3.405

4.  Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Authors:  Terence C Chua; Brendan J Moran; Paul H Sugarbaker; Edward A Levine; Olivier Glehen; François N Gilly; Dario Baratti; Marcello Deraco; Dominique Elias; Armando Sardi; Winston Liauw; Tristan D Yan; Pedro Barrios; Alberto Gómez Portilla; Ignace H J T de Hingh; Wim P Ceelen; Joerg O Pelz; Pompiliu Piso; Santiago González-Moreno; Kurt Van Der Speeten; David L Morris
Journal:  J Clin Oncol       Date:  2012-05-21       Impact factor: 44.544

5.  Lymph node metastasis in epithelial malignancies of the appendix with peritoneal dissemination does not reduce survival in patients treated by cytoreductive surgery and perioperative intraperitoneal chemotherapy.

Authors:  S González-Moreno; E Brun; P H Sugarbaker
Journal:  Ann Surg Oncol       Date:  2004-12-27       Impact factor: 5.344

6.  Classification of and cytoreductive surgery for low-grade appendiceal mucinous neoplasms.

Authors:  J R McDonald; S T O'Dwyer; S Rout; B Chakrabarty; K Sikand; P E Fulford; M S Wilson; A G Renehan
Journal:  Br J Surg       Date:  2012-04-20       Impact factor: 6.939

7.  Prognostic significance of localized extra-appendiceal mucin deposition in appendiceal mucinous neoplasms.

Authors:  Rhonda K Yantiss; Jinru Shia; David S Klimstra; Hejin P Hahn; Robert D Odze; Joseph Misdraji
Journal:  Am J Surg Pathol       Date:  2009-02       Impact factor: 6.394

8.  A Consensus for Classification and Pathologic Reporting of Pseudomyxoma Peritonei and Associated Appendiceal Neoplasia: The Results of the Peritoneal Surface Oncology Group International (PSOGI) Modified Delphi Process.

Authors:  Norman J Carr; Thomas D Cecil; Faheez Mohamed; Leslie H Sobin; Paul H Sugarbaker; Santiago González-Moreno; Panos Taflampas; Sara Chapman; Brendan J Moran
Journal:  Am J Surg Pathol       Date:  2016-01       Impact factor: 6.394

9.  Appendiceal mucinous neoplasms: clinicopathologic study of 116 cases with analysis of factors predicting recurrence.

Authors:  Reetesh K Pai; Andrew H Beck; Jeffrey A Norton; Teri A Longacre
Journal:  Am J Surg Pathol       Date:  2009-10       Impact factor: 6.394

Review 10.  Appendix tumors in the era of laparoscopic appendectomy.

Authors:  P Bucher; Z Mathe; A Demirag; Ph Morel
Journal:  Surg Endosc       Date:  2004-05-27       Impact factor: 4.584

View more
  2 in total

1.  Clinicopathological Characteristics of Pseudomyxoma Peritonei Originated from Ovaries.

Authors:  Fengcai Yan; Feng Shi; Xinbao Li; Chunkai Yu; Yulin Lin; Yan Li; Mulan Jin
Journal:  Cancer Manag Res       Date:  2020-08-21       Impact factor: 3.989

2.  Trends of colorectal cancer incidence according to age, anatomic site, and histological subgroup in Bavaria: A registry-based study.

Authors:  Sven Voigtländer; Amir Hakimhashemi; Nina Grundmann; Franziska Rees; Martin Meyer; Hana Algül; Jacqueline Müller-Nordhorn
Journal:  Front Oncol       Date:  2022-09-20       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.